ZSQR · Z Squared Inc.
Substantial doubt about the company's ability to continue as a going concern.
“Substantial doubt about the Registrant’s ability to continue as a going concern, as identified in the Annual Report, continues to apply, and Old Z Squared’s historical financial statements have also reflected substantial doubt about its ability to continue as a going concern. Neither the Merger nor the Spin-Out, individually, has eliminated those concerns.”View the 10-Q filed Aug 13, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-24 | Harris Jeffery Keeslar |
Chief Technology Officer |
Other↑
|
No Securities Owned
|
0 |
| 2026-06-03 | Schadel Christopher Ryan |
Chief Marketing Officer |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Represents Restricted stock units ("RSUs") granted under the issuer's 2025 Incentive Compensation Plan as a supplemental award in respect of the annual bonus under Section 3(b) of the reporting person's Executive Employment Agreement, dated April 27, 2026. The number of RSUs was determined by dividing $30,000 by the closing price per share on the Nasdaq Global Market on June 3, 2026 ($10.69), rounded down to the nearest whole share. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The RSUs vest in equal quarterly installments over the one-year period commencing June 3, 2026, subject to continued employment on each vesting date. |
Restricted Stock Units
|
2,806 |
| 2026-04-30 | BSG Series CM, LLC |
10% Owner |
Other↓
Filing footnotes — Common Stock, $0.0001 par value (Direct)
On April 30, 2026 (the "Distribution Date"), the Reporting Person completed a pro rata distribution (the "Distribution") of all 41,521,276 shares of Common Stock of the Issuer then held by it to its members, in accordance with their respective percentage membership interests. No monetary consideration was paid or received by the Reporting Person or its members in connection with the Distribution. Following the Distribution, the Reporting Person does not beneficially own any shares of Common Stock of the Issuer and is no longer subject to the reporting requirements of Section 16(a) of the Securities Exchange Act of 1934, as amended. This Form 4 constitutes the final Section 16 report filed by the Reporting Person with respect to the Common Stock of the Issuer. |
Common Stock, $0.0001 par value
|
41,521,276 |
| 2026-04-27 | Schadel Christopher Ryan |
Chief Marketing Officer |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Iin addition, pursuant to the Employment Agreement, the issuer agreed to grant the reporting person an annual bonus of restricted stock units ("RSUs") having a grant-date fair market value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the closing price per share of the common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). The RSUs vest in equal quarterly installments over one year commencing on April 27, 2026, subject to the reporting person's continued employment with the issuer on each vesting date. |
Restricted Stock Units
|
9,868 |
| 2026-04-27 | Sohn Adam Craig |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date. |
Restricted Stock Units
|
9,868 |
| 2026-04-27 | Fuerst Bryan Eric |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date. |
Restricted Stock Units
|
9,868 |
| 2026-04-27 | Halabu David Elias |
Director, Co-Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On April 27, 2026, the issuer and the reporting person entered into an Amended and Restated Executive Employment Agreement (the "A&R Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 500,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(d) of the A&R Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement. |
Stock Option (Right to Buy)
|
500,000 |
| 2026-04-27 | Cogley Brian |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On April 27, 2026, the issuer and the reporting person entered into an Amended and Restated Executive Employment Agreement (the "A&R Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 100,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(c) of the A&R Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement. |
Stock Option (Right to Buy)
|
100,000 |
| 2026-04-27 | Burke Michelle Ellen |
Director, Co-Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
On April 27, 2026, the issuer entered into an Amendment to Service Agreement with the reporting person, pursuant to which the issuer agreed to issue $1,000,000 worth of shares of the issuer's common stock to the reporting person, payable in four equal quarterly tranches. The shares reported herein represent the first such tranche, issued pursuant to the Z Squared, Inc. 2025 Incentive Compensation Plan. The number of shares reported was determined by dividing $250,000 by the closing price per share of the issuer's common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). |
Common Stock
|
16,447 |
| 2026-04-27 | Schadel Christopher Ryan |
Chief Marketing Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
On April 27, 2026, the issuer and the reporting person entered into an Executive Employment Agreement (the "Employment Agreement"), pursuant to which the issuer agreed to grant the reporting person an option to purchase 100,000 shares of common stock at an exercise price equal to the fair market value of the common stock on the grant date. The Stock Option was granted pursuant to Section 3(c) of the Employment Agreement and the Z Squared, Inc. 2025 Incentive Compensation Plan. The Stock Option vests in full on the date the fair market value of the common stock increases by 50% above the grant-date fair market value, as determined by the Board in its reasonable discretion, and remains exercisable for ten (10) years from the grant date, subject to earlier termination under the 2025 Plan and applicable award agreement. |
Stock Option (Right to Buy)
|
100,000 |
| 2026-04-27 | Cogley Brian |
Chief Financial Officer |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting. The number of RSUs reported was determined by dividing $250,000 by the closing price per share of the issuer's common stock on the Nasdaq Global Market on April 27, 2026 (rounded down to the nearest whole share). The RSUs vest in equal quarterly installments over the one-year period commencing on April 27, 2026, subject to the reporting person's continued employment with the issuer (or its applicable subsidiary) on each applicable vesting date. The RSUs do not have an expiration date. The RSUs were granted pursuant to Section 3(b) of the Amended and Restated Executive Employment Agreement, dated as of April 27, 2026, by and between the issuer and the reporting person and the Z Squared Inc. 2025 Incentive Compensation Plan. |
Restricted Stock Units
|
16,447 |
| 2026-04-27 | Cooper Kenneth Lyle |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
On June 4, 2025, the issuer's predecessor (Z Squared, Inc., a Wyoming corporation) and the reporting person entered into an Independent Director Agreement, pursuant to which the reporting person was granted an initial award of restricted stock units ("RSUs") having a grant-date fair value of $150,000. The RSUs were granted pursuant to Section 3(b) of the Independent Director Agreement, the issuer's 2025 Incentive Compensation Plan, and Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting and has no expiration date. The number of RSUs reported was determined by dividing $150,000 by the fair market value of the common stock on April 27, 2026 (the grant date), rounded down to the nearest whole share. The RSUs vest in thirty-six (36) equal monthly installments commencing April 27, 2026, subject to the reporting person's continued Board service through each vesting date. |
Restricted Stock Units
|
9,868 |
| 2026-04-24 | Schadel Christopher Ryan |
Chief Marketing Officer |
Other↑
|
No Securities Owned
|
0 |
| 2026-04-24 | Cooper Kenneth Lyle |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-04-24 | Sohn Adam Craig |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-04-24 | Fuerst Bryan Eric |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-04-24 | Burke Michelle Ellen |
Director, Co-Chief Executive Officer |
Other↑
|
No Securities Owned
|
0 |
| 2026-02-11 | DeSilva Tara |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. |
Common Stock
|
3,250 |
| 2026-02-11 | Deschamps Philippe |
Director, President and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. |
Common Stock
|
3,250 |
| 2026-02-11 | Yerace Daniel Alexander |
Director, VP Operations |
Convert↑
Filing footnotes — Common stock (Direct)
Represents the weighted average exercise price of shares purchased upon exercise of stock options. |
Common stock
|
10,000 |
| 2026-02-11 | Cochran Christopher P. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. |
Common Stock
|
3,250 |
| 2026-02-11 | Cogley Brian |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. |
Common Stock
|
12,500 |
| 2026-02-11 | Calise Chris |
Director |
Award↑
Filing footnotes — Common stock (Direct)
Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. Includes (i) 49,500 shares of common stock that are owned by CJC Investment Trust (a Trust in which Mr. Calise is a control person), and (ii) 47,106 shares of common stock that are issuable under currently exercisable warrants. |
Common stock
|
3,250 |
| 2026-02-11 | Sheehy Christine Elise |
VP Compliance and Secy |
Convert↑
Filing footnotes — Common stock (Direct)
Represents the exercise price of shares purchased upon exercise of stock options. |
Common stock
|
1,000 |
| 2026-02-11 | Deschamps Philippe |
Director, President and CEO |
Convert↑
Filing footnotes — Common stock (Direct)
Represents the exercise price of shares purchased upon exercise of stock options. |
Common stock
|
5,700 |
| 2026-02-11 | Calise Chris |
Director |
Convert↑
Filing footnotes — Common stock (Direct)
Represents the exercise price of shares purchased upon exercise of stock options. Includes (i) 49,500 shares of common stock that are owned by CJC Investment Trust (a Trust in which Mr. Calise is a control person), and (ii) 47,106 shares of common stock that are issuable under currently exercisable warrants. |
Common stock
|
5,700 |
| 2026-02-11 | Salkind Gene |
Director, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. Includes 4,211 shares of common stock that are held as JTWROS with Catherine Salkind. |
Common Stock
|
3,250 |
| 2026-02-11 | Mehalick David |
Director, CEO and President, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. |
Common Stock
|
51,250 |
| 2026-02-11 | Mehalick David |
Director, CEO and President, 10% Owner |
Convert↑
Filing footnotes — Common stock (Direct)
Represents the weighted average exercise price of shares purchased upon exercise of stock options. |
Common stock
|
148,875 |
| 2026-02-11 | Sheehy Christine Elise |
VP Compliance and Secy |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. |
Common Stock
|
12,500 |
| 2026-02-11 | DeSilva Tara |
Director |
Convert↑
Filing footnotes — Common stock (Direct)
Represents the exercise price of shares purchased upon exercise of stock options. |
Common stock
|
5,700 |
| 2026-02-11 | Salkind Gene |
Director, 10% Owner |
Convert↑
Filing footnotes — Common stock (Direct)
Represents the exercise price of shares purchased upon exercise of stock options. Includes 4,211 shares of common stock that are held as JTWROS with Catherine Salkind. |
Common stock
|
5,700 |
| 2026-02-11 | Yerace Daniel Alexander |
Director, VP Operations |
Award↑
Filing footnotes — Common Stock (Direct)
Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. |
Common Stock
|
20,000 |
| 2026-02-11 | Cogley Brian |
Chief Financial Officer |
Convert↑
Filing footnotes — Common stock (Direct)
Represents the exercise price of shares purchased upon exercise of stock options. |
Common stock
|
10,000 |
| 2026-02-11 | Cochran Christopher P. |
Director |
Convert↑
Filing footnotes — Common stock (Direct)
Represents the exercise price of shares purchased upon exercise of stock options. |
Common stock
|
5,700 |
| 2025-03-04 | Cochran Christopher P. |
Director |
Award↑
Filing footnotes — Non-qualified Stock Options (right to buy) (Direct)
On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan. The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25. Expiration date is ten years from the day of grant. |
Non-qualified Stock Options (right to buy)
|
5,700 |
| 2025-03-04 | Deschamps Philippe |
Director, President and CEO |
Award↑
Filing footnotes — Non-qualified Stock Options (right to buy) (Direct)
On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan. The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25. Expiration date is ten years from the day of grant. |
Non-qualified Stock Options (right to buy)
|
5,700 |
| 2025-03-04 | Cogley Brian |
Chief Financial Officer |
Award↑
Filing footnotes — Non-Qualified Stock Options (right to buy) (Direct)
On March 4, 2025, the reporting person received a grant of 10,000 non-qualified stock options, under the 2022 equity incentive plan. The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28. Expiration date is ten years from the day of grant. |
Non-Qualified Stock Options (right to buy)
|
10,000 |
| 2025-03-04 | DeSilva Tara |
Director |
Award↑
Filing footnotes — Non-qualified Stock Options (right to buy) (Direct)
On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan. The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25. Expiration date is ten years from the day of grant. |
Non-qualified Stock Options (right to buy)
|
5,700 |
| 2025-03-04 | Sheehy Christine Elise |
VP Compliance and Secy |
Award↑
Filing footnotes — Non-Qualified Stock Options (right to buy) (Direct)
On March 4, 2025, the reporting person received a grant of 1,000 non-qualified stock options, under the 2022 equity incentive plan. The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28. Expiration date is ten years from the day of grant. |
Non-Qualified Stock Options (right to buy)
|
1,000 |
| 2025-03-04 | Salkind Gene |
Director, 10% Owner |
Award↑
Filing footnotes — Non-qualified Stock Options (right to buy) (Direct)
On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan. The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25. Expiration date is ten years from the day of grant. |
Non-qualified Stock Options (right to buy)
|
5,700 |
| 2025-03-04 | Calise Chris |
Director |
Award↑
Filing footnotes — Non-qualified Stock Options (right to buy) (Direct)
On March 4, 2025, the reporting person received a grant of 5,700 stock options, as non-qualified options, under the 2022 equity incentive plan. The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2025, the next 25% vesting on 6/30/2025, the next 25% vesting on 9/30/25, and the final 25% vesting on 12/31/25. Expiration date is ten years from the day of grant. |
Non-qualified Stock Options (right to buy)
|
5,700 |
| 2025-03-04 | Mehalick David |
Director, CEO and President, 10% Owner |
Award↑
Filing footnotes — Non-Qualified Stock Options (right to buy) (Direct)
On March 4, 2025, the reporting person received a grant of 28,875 non-qualified stock options, under the 2022 equity incentive plan. The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28. Expiration date is ten years from the day of grant. |
Non-Qualified Stock Options (right to buy)
|
28,875 |
| 2025-03-04 | Yerace Daniel Alexander |
Director, VP Operations |
Award↑
Filing footnotes — Non-Qualified Stock Options (right to buy) (Direct)
On March 4, 2025, the reporting person received a grant of 5,000 non-qualified stock options, under the 2022 equity incentive plan. The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28. Expiration date is ten years from the day of grant. |
Non-Qualified Stock Options (right to buy)
|
5,000 |
| 2024-01-12 | DeSilva Tara |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Includes 30,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. |
Common Stock
|
466 |
| 2024-01-12 | DeSilva Tara |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Includes 30,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. |
Common Stock
|
1,800 |
| 2024-01-10 | Cogley Brian |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Includes 25,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. |
Common Stock
|
5,000 |
| 2024-01-08 | Mehalick David |
Director, CEO and President, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days. |
Common Stock
|
14,004 |
| 2024-01-08 | Mehalick David |
Director, CEO and President, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days. |
Common Stock
|
6,000 |
| 2024-01-05 | Mehalick David |
Director, CEO and President, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days. |
Common Stock
|
5,050 |